vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and BILL Holdings, Inc. (BILL). Click either name above to swap in a different company.
BILL Holdings, Inc. is the larger business by last-quarter revenue ($414.7M vs $284.0M, roughly 1.5× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -0.6%, a 97.0% gap on every dollar of revenue. On growth, BILL Holdings, Inc. posted the faster year-over-year revenue change (14.4% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
BILL Holdings, Inc. is an American company based in San Jose, California, that provides automated, cloud-based software for financial operations for small businesses in the United States. A white-labeled, end-to-end payments automation platform, Bill.com Connect is offered to financial institutions as part of their single sign-on online business banking ecosystem.
ACAD vs BILL — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $414.7M |
| Net Profit | $273.6M | $-2.6M |
| Gross Margin | 90.8% | 79.8% |
| Operating Margin | 6.1% | -4.4% |
| Net Margin | 96.3% | -0.6% |
| Revenue YoY | 9.4% | 14.4% |
| Net Profit YoY | 90.3% | -107.7% |
| EPS (diluted) | $1.61 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $414.7M | ||
| Q3 25 | $278.6M | $395.7M | ||
| Q2 25 | $264.6M | $383.3M | ||
| Q1 25 | $244.3M | $358.2M | ||
| Q4 24 | $259.6M | $362.6M | ||
| Q3 24 | $250.4M | $358.4M | ||
| Q2 24 | $242.0M | $343.7M | ||
| Q1 24 | $205.8M | $323.0M |
| Q4 25 | $273.6M | $-2.6M | ||
| Q3 25 | $71.8M | $-3.0M | ||
| Q2 25 | $26.7M | $-7.1M | ||
| Q1 25 | $19.0M | $-11.6M | ||
| Q4 24 | $143.7M | $33.5M | ||
| Q3 24 | $32.8M | $8.9M | ||
| Q2 24 | $33.4M | $7.6M | ||
| Q1 24 | $16.6M | $31.8M |
| Q4 25 | 90.8% | 79.8% | ||
| Q3 25 | 92.2% | 80.5% | ||
| Q2 25 | 92.2% | 80.8% | ||
| Q1 25 | 91.7% | 81.2% | ||
| Q4 24 | 91.6% | 81.6% | ||
| Q3 24 | 92.5% | 82.0% | ||
| Q2 24 | 92.5% | 81.0% | ||
| Q1 24 | 88.8% | 83.0% |
| Q4 25 | 6.1% | -4.4% | ||
| Q3 25 | 12.8% | -5.2% | ||
| Q2 25 | 12.2% | -5.8% | ||
| Q1 25 | 7.9% | -8.1% | ||
| Q4 24 | 59.1% | -6.0% | ||
| Q3 24 | 12.6% | -2.1% | ||
| Q2 24 | 12.6% | -6.5% | ||
| Q1 24 | 7.4% | -8.6% |
| Q4 25 | 96.3% | -0.6% | ||
| Q3 25 | 25.8% | -0.7% | ||
| Q2 25 | 10.1% | -1.8% | ||
| Q1 25 | 7.8% | -3.2% | ||
| Q4 24 | 55.4% | 9.3% | ||
| Q3 24 | 13.1% | 2.5% | ||
| Q2 24 | 13.8% | 2.2% | ||
| Q1 24 | 8.0% | 9.8% |
| Q4 25 | $1.61 | $-0.03 | ||
| Q3 25 | $0.42 | $-0.03 | ||
| Q2 25 | $0.16 | $0.02 | ||
| Q1 25 | $0.11 | $-0.11 | ||
| Q4 24 | $0.86 | $-0.06 | ||
| Q3 24 | $0.20 | $0.08 | ||
| Q2 24 | $0.20 | $0.37 | ||
| Q1 24 | $0.10 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $1.1B |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | $1.2B | $3.8B |
| Total Assets | $1.6B | $10.1B |
| Debt / EquityLower = less leverage | — | 0.48× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $1.1B | ||
| Q3 25 | $258.0M | $1.1B | ||
| Q2 25 | $253.6M | $1.0B | ||
| Q1 25 | $217.7M | $1.0B | ||
| Q4 24 | $319.6M | $1.6B | ||
| Q3 24 | $155.1M | $853.5M | ||
| Q2 24 | $177.1M | $985.9M | ||
| Q1 24 | $204.7M | $952.5M |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $914.8M | ||
| Q2 24 | — | $914.0M | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $1.2B | $3.8B | ||
| Q3 25 | $917.3M | $3.9B | ||
| Q2 25 | $822.4M | $3.9B | ||
| Q1 25 | $765.2M | $3.9B | ||
| Q4 24 | $732.8M | $3.8B | ||
| Q3 24 | $577.2M | $4.0B | ||
| Q2 24 | $516.7M | $4.1B | ||
| Q1 24 | $464.0M | $4.1B |
| Q4 25 | $1.6B | $10.1B | ||
| Q3 25 | $1.3B | $10.2B | ||
| Q2 25 | $1.2B | $10.1B | ||
| Q1 25 | $1.1B | $9.6B | ||
| Q4 24 | $1.2B | $9.7B | ||
| Q3 24 | $976.9M | $9.0B | ||
| Q2 24 | $914.1M | $9.2B | ||
| Q1 24 | $855.1M | $9.1B |
| Q4 25 | — | 0.48× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.44× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $105.3M |
| Free Cash FlowOCF − Capex | — | $103.8M |
| FCF MarginFCF / Revenue | — | 25.0% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $378.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $105.3M | ||
| Q3 25 | $74.3M | $96.9M | ||
| Q2 25 | $64.0M | $83.8M | ||
| Q1 25 | $20.3M | $99.5M | ||
| Q4 24 | $40.4M | $78.7M | ||
| Q3 24 | $63.2M | $88.6M | ||
| Q2 24 | $25.0M | $78.6M | ||
| Q1 24 | $29.1M | $66.8M |
| Q4 25 | — | $103.8M | ||
| Q3 25 | $73.9M | $95.6M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $98.4M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | $63.2M | $88.6M | ||
| Q2 24 | — | $78.4M | ||
| Q1 24 | — | $66.8M |
| Q4 25 | — | 25.0% | ||
| Q3 25 | 26.5% | 24.1% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 27.5% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | 25.2% | 24.7% | ||
| Q2 24 | — | 22.8% | ||
| Q1 24 | — | 20.7% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | 2.35× | ||
| Q3 24 | 1.93× | 9.94× | ||
| Q2 24 | 0.75× | 10.35× | ||
| Q1 24 | 1.76× | 2.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
BILL
| Accounts Payable And Accounts Receivable Solutions | $185.9M | 45% |
| Spend And Expense Interchange Revenue | $166.5M | 40% |
| Interest On Funds Held For Customers | $39.5M | 10% |
| Embedded And Other Solutions | $22.8M | 5% |
